Atlas Trials

Study to Assess the Safety of Ipratropium Bromide, in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Clinical trial NCT02236182 · COMPLETED

Trial details

NCT number
NCT02236182
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pulmonary Disease, Chronic Obstructive
Start date
1998-07-01
Primary completion
1999-02-01
Enrollment
57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.